Company filings, made visual.

Find a company. Follow its revenue through costs and profit.

Market

Find a company or ticker

Coverage includes separate ticker and security records; counts are not unique companies.

Elanco Animal Health Incorporated

ELAN

Filing: SEC 10-Q
Period: Three months ended March 31, 2026
Basis: Editorial filing; Read original SEC 10-Q ↗

Sankey diagram of Elanco Animal Health Incorporated. A complete text table follows the diagram.

Elanco Converts Animal Health Products Into Global Revenue

Animal-health products dominate the consolidated quarter.

Swipe to explore

Source & review

Read original SEC 10-Q ↗

SEC accession: 0001739104-26-000030
Filed: Date not recorded
Reviewed: Date not recorded
Status: Individual filing review complete

How to read these figures

Labels and displayed flow values are reported filing values or exact disclosed subtotals.

Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.

The filing reports $1,371M revenue; no unsupported product allocation is added.

View accessible tables

Financial categories · Three months ended March 31, 2026 · Millions of USD
Category	Stage	Value	Notes
Elanco Animal Health Incorporated revenue	1	$1.4B	$1,371.0M reported quarterly revenue
Animal health products and contract manufacturing	2	$1.4B	Reported revenue

Financial flows · Millions of USD
From	To	Value
Elanco Animal Health Incorporated revenue	Animal health products and contract manufacturing	$1.4B